Cited by 339Phytochemicals and Medicinal PlantsMedicinal Plants and NeuroprotectionNerve injury and regeneration

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Neuritic regeneration and synaptic reconstruction induced by withanolide A

Open access

Kuboyama, Tomoharu, Tohda, Chihiro, Komatsu, Katsuko·2005·British Journal of Pharmacology

DOI 10.1038/sj.bjp.0706122PMC PMC1576076

Open this paper in CoChat — free account Open PDF

Abstract

We investigated whether withanolide A (WL-A), isolated from the Indian herbal drug Ashwagandha (root of Withania somnifera), could regenerate neurites and reconstruct synapses in severely damaged neurons. We also investigated the effect of WL-A on memory-deficient mice showing neuronal atrophy and synaptic loss in the brain. Axons, dendrites, presynapses, and postsynapses were visualized by immunostaining for phosphorylated neurofilament-H (NF-H), microtubule-associated protein 2 (MAP2), synaptophysin, and postsynaptic density-95 (PSD-95), respectively. Treatment with A beta(25-35) (10 microM) induced axonal and dendritic atrophy, and pre- and postsynaptic loss in cultured rat cortical neurons. Subsequent treatment with WL-A (1 microM) induced significant regeneration of both axons and dendrites, in addition to the reconstruction of pre- and postsynapses in the neurons. WL-A (10 micromol kg(-1) day(-1), for 13 days, p.o.) recovered A beta(25-35)-induced memory deficit in mice. At that time, the decline of axons, dendrites, and synapses in the cerebral cortex and hippocampus was almost recovered. WL-A is therefore an important candidate for the therapeutic treatment of neurodegenerative diseases, as it is able to reconstruct neuronal networks.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0706122

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Retracted:Nootropic‐like effect of ashwagandha (Withania somnifera L.) in mice
Dhuley, J. N. (2001) · Phytotherapy Research · doi:10.1002/ptr.874 · Cited by 85
Retracted
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurotrophins regulate dendritic growth in developing visual cortex
McAllister, A. K., Lo, D. C., & Katz, L. C. (1995) · Neuron · doi:10.1016/0896-6273(95)90171-x · Cited by 959
Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity
Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699
Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction
Maurice, T., Lockhart, B. P., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01032-7 · Cited by 530
Assembly of New Individual Excitatory Synapses
Friedman, H., Bresler, T., Garner, C. C., & Ziv, N. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)00009-x · Cited by 499
Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro.
Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I. M., Becker, G. W., & Brems, D. N. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10007-2 · Cited by 371

Flagged first, then by citations

Show all 45 references

1 of the 45 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 339

Toxic Chemical Compounds of the Solanaceae
Pomilio, A. B., Falzoni, E., & Vitale, A. A. (2008) · Natural Product Communications · doi:10.1177/1934578x0800300420 · Cited by 45
Withania somnifera Prevents Morphine Withdrawal-Induced Decrease in Spine Density in Nucleus Accumbens Shell of Rats: A Confocal Laser Scanning Microscopy Study
Kasture, S. B., Vinci, S., Ibba, F., Puddu, A., Marongiu, M., Balasubramanian, M., Pisanu, A., Lecca, D., Zernig, G., & Acquas, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9069-2 · Cited by 44
Nootropic potential of Ashwagandha leaves: Beyond traditional root extracts
Wadhwa, R., Konar, A., & Kaul, S. C. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.09.001 · Cited by 43
Polygalae Radix Extract Prevents Axonal Degeneration and Memory Deficits in a Transgenic Mouse Model of Alzheimer’s Disease
Kuboyama, T., Hirotsu, K., Arai, T., Yamasaki, H., & Tohda, C. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00805 · Cited by 42
Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice
Kushwaha, S., Roy, S., Maity, R., Mallick, A., Soni, V. K., Singh, P. K., Chaurasiya, N. D., Sangwan, R. S., Misra‐Bhattacharya, S., & Mandal, C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.12.031 · Cited by 43
Withanolide A production from Withania somnifera hairy root cultures with improved growth by altering the concentrations of macro elements and nitrogen source in the medium
Nagella, P., & Murthy, H. N. (2012) · Acta Physiologiae Plantarum · doi:10.1007/s11738-012-1125-5 · Cited by 42
Light and auxin responsive cytochrome P450s from Withania somnifera Dunal: cloning, expression and molecular modelling of two pairs of homologue genes with differential regulation
Srivastava, S., Sangwan, R. S., Tripathi, S., Mishra, B., Narnoliya, L. K., Misra, L., & Sangwan, N. S. (2015) · PROTOPLASMA · doi:10.1007/s00709-015-0766-9 · Cited by 41
[Retracted] Protective Effects of Rosa damascena and Its Active Constituent on Aβ(25–35)‐Induced Neuritic Atrophy
Awale, S., Tohda, C., Tezuka, Y., Miyazaki, M., & Kadota, S. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep149 · Cited by 42
Retracted
Heterophyllin B, a cyclopeptide from Pseudostellaria heterophylla, improves memory via immunomodulation and neurite regeneration in i.c.v.Aβ-induced mice
Deng, J., Feng, X., Zhou, L., He, C., Li, H., Xia, J., Ge, Y., Zhao, Y., Song, C., Chen, L., et al. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111576 · Cited by 39
Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease
Chakraborty, B., Mukerjee, N., Maitra, S., Zehravi, M., Mukherjee, D., Ghosh, A., Massoud, E. E. S., & Rahman, M. H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6873874 · Cited by 42
Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine System from the Modern Viewpoint
Kushwah, S., Maurya, N. S., Kushwaha, S. K., Scotti, L., Chawade, A., & Mani, A. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230216094353 · Cited by 42
The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells
Jesky, R., & Chen, H. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1006-3 · Cited by 38
Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy
Singh, M., Jayant, K., Singh, D., Bhutani, S., Poddar, N. K., Chaudhary, A. A., Khan, S.-U.-D., Adnan, M., Siddiqui, A. J., Hassan, M. I., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.933824 · Cited by 41
Synthesis of Sominone and Its Derivatives Based on an RCM Strategy: Discovery of A Novel Anti-Alzheimer’s Disease Medicine Candidate “Denosomin”
Matsuya, Y., Yamakawa, Y.-I., Tohda, C., Teshigawara, K., Yamada, M., & Nemoto, H. (2009) · Organic Letters · doi:10.1021/ol901553w · Cited by 38
Secondary Metabolites of Traditional Medical Plants: A Case Study of Ashwagandha (Withania somnifera)
Sangwan, N. S., & Sangwan, R. S. (2013) · Plant cell monographs · doi:10.1007/978-3-642-41787-0_11 · Cited by 38
Dynamics of withanolide biosynthesis in relation to temporal expression pattern of metabolic genes in Withania somnifera (L.) Dunal: a comparative study in two morpho-chemovariants
Dhar, N., Rana, S., Bhat, W. W., Razdan, S., Pandith, S. A., Khan, S., Dutt, P., Dhar, R. S., Vaishnavi, S., Vishwakarma, R. A., et al. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2820-z · Cited by 37
Biotransformation of withanolides by cell suspension cultures of Withania somnifera (Dunal)
Sabir, F., Sangwan, R. S., Singh, J., Misra, L. N., Pathak, N., & Sangwan, N. S. (2011) · Plant Biotechnology Reports · doi:10.1007/s11816-011-0165-4 · Cited by 37
Aqueous Leaf Extract of Withania somnifera as a Potential Neuroprotective Agent in Sleep-deprived Rats: a Mechanistic Study
Manchanda, S., Mishra, R., Singh, R., Kaur, T., & Kaur, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9883-5 · Cited by 38
β-Amyloid1-42, HIV-1Ba-L (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A
Kurapati, K. R. V., Samikkannu, T., Atluri, V. S. R., Kaftanovskaya, E. M., Yndart, A., & Nair, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112818 · Cited by 37
Sominone Improves Memory Impairments and Increases Axonal Density in Alzheimer's Disease Model Mice, 5XFAD
Joyashiki, E., Matsuya, Y., & Tohda, C. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2010.541571 · Cited by 39
Potential clinical applications of Ashwagandha (Withania somnifera) in medicine and neuropsychiatry
D’Cruz, M., & Andrade, C. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2121699 · Cited by 40
Kihi-to, a herbal traditional medicine, improves Abeta(25–35)-induced memory impairment and losses of neurites and synapses
Tohda, C., Naito, R., & Joyashiki, E. (2008) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-8-49 · Cited by 36
Diosgenin restores Aβ-induced axonal degeneration by reducing the expression of heat shock cognate 70 (HSC70)
Yang, X., & Tohda, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-30102-8 · Cited by 35
Synthesis of dihydrofuran-fused perhydrophenanthrenes having a phenolic hydroxyl group as a novel anti-Alzheimer’s disease agent
Sugimoto, K., Tamura, K., Ohta, N., Tohda, C., Toyooka, N., Nemoto, H., & Matsuya, Y. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.127 · Cited by 35
Indian Ginseng (Withania somnifera) supplementation ameliorates oxidative stress and mitochondrial dysfunctions in experimental model of stroke
Sood, A., Mehrotra, A., Dhawan, D. K., & Sandhir, R. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0234-2 · Cited by 35
Withanolide A: synthesis and structural requirements for neurite outgrowth
Liffert, R., Hoecker, J., Jana, C. K., Woods, T. M., Burch, P., Jessen, H. J., Neuburger, M. A., & Gademann, K. (2013) · Chemical Science · doi:10.1039/c3sc50653c · Cited by 34
Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials
Tamura, J. K., Carvalho, I. P., Lui, L. M. W., Feng, J. N., Rosenblat, J. D., Mansur, R. B., Lee, Y. L., Cha, D. S., Teopiz, K. M., Ahmad, Z., et al. (2021) · CNS Spectrums · doi:10.1017/s1092852921000092 · Cited by 35
Active Constituents from Drynaria fortunei Rhizomes on the Attenuation of Aβ 25–35 -Induced Axonal Atrophy
Yang, Z., Kuboyama, T., Kazuma, K., Konno, K., & Tohda, C. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00290 · Cited by 33
Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive model.
Ramanathan, M., Balaji, B., & Justin, A. (2011) · PubMed · Cited by 32
Ameliorative Effects of Nutraceuticals in Neurological Disorders
Chauhan, N. B., & Mehla, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411462-3.00027-8 · Cited by 32
The pathomimetic oAβ25–35 model of Alzheimer's disease: Potential for screening of new therapeutic agents
Canet, G., Zussy, C., Hernandez, C., Maurice, T., Desrumaux, C. M., & Givalois, L. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108398 · Cited by 34
Major biochemical constituents of Withania somnifera (ashwagandha) extract: A review of chemical analysis
Abdelwahed, M. T., Hegazy, M. A. M., & Mohamed, E. H. (2023) · Reviews in Analytical Chemistry · doi:10.1515/revac-2022-0055 · Cited by 31
Impaired motor learning attributed to altered AMPA receptor function in the cerebellum of rats with temporal lobe epilepsy: Ameliorating effects of Withania somnifera and withanolide A
Soman, S. K., Anju, T. R., Jayanarayanan, S., Antony, S., & Paulose, C. S. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.01.007 · Cited by 31
Withania somnifera prevents acquisition and expression of morphine-elicited conditioned place preference
Ruiu, S., Longoni, R., Spina, L., Orrù, A., Cottiglia, F., Collu, M., Kasture, S. B., & Acquas, E. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835f3d15 · Cited by 31
Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost
Kaur, A., Singh, B. B., Ohri, P., Wang, J., Wadhwa, R., Kaul, S. C., Pati, P. K., & Kaur, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194314 · Cited by 30
Indian Herbs for the Treatment of Neurodegenerative Disease
Mannangatti, P., & Naidu, K. N. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_17 · Cited by 30
The Multifaceted Role of Neuroprotective Plants in Alzheimer’s Disease Treatment
Zieneldien, T., Kim, J., & Cao, C. (2022) · Geriatrics · doi:10.3390/geriatrics7020024 · Cited by 29
“Additionally, the ameliorative outcomes were retained after treatment discontinuation [89].”
Background
Longevity promoting efficacies of different plant extracts in lower model organisms
Chattopadhyay, D., & Thirumurugan, K. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.002 · Cited by 30
Contemporary advancements in the semi-synthesis of bioactive terpenoids and steroids
Wang, Z., & Hui, C. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00448d · Cited by 31
Ethnopharmacological Review of Native Traditional Medicinal Plants for Brain Disorders
Husain, G. M., Mishra, D., Singh, P., Rao, C. V., & Kumar, V. (2007) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · Cited by 27
Neuropharmacological Properties of Withania somnifera - Indian Ginseng: An Overview on Experimental Evidence with Emphasis on Clinical Trials and Patents
Yenisetti, S. C., Manjunath, M. J., & ., M. (2016) · Recent Patents on CNS Drug Discovery · doi:10.2174/1574889810666160615014106 · Cited by 29
Clathrin mediated endocytosis in Alzheimer’s disease: cell type specific involvement in amyloid beta pathology
Jaye, S., Sandau, U. S., & Saugstad, J. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1378576 · Cited by 26
The Role of Adaptogens in Stress Management
Provino, R. (2010) · Australian journal of medical herbalism · Cited by 26
Effects of Oleanane-Type Triterpene Saponins from the Leaves of Eleutherococcus senticosus in an Axonal Outgrowth Assay
Ge, Y., Tohda, C., Zhu, S., He, Y., Yoshimatsu, K., & Komatsu, K. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00329 · Cited by 26
Inhibition of clathrin-mediated endocytosis prevents amyloid β-induced axonal damage
Kuboyama, T., Lee, Y., Nishiko, H., & Tohda, C. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.02.005 · Cited by 27
Carbon sources and medium pH affects the growth ofWithania somnifera(L.) Dunal adventitious roots and withanolide A production
Murthy, H. N., & Nagella, P. (2012) · Natural Product Research · doi:10.1080/14786419.2012.660691 · Cited by 25
Medhya Rasayanas in Brain Function and Disease
Ray, S. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000309 · Cited by 26
Medical Plants and Nutraceuticals for Amyloid-β Fibrillation Inhibition
Witter, S., Witter, R., Vilu, R., & Samoson, A. (2018) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180066 · Cited by 25
Experimental evidence and mechanism of action of some popular neuro-nutraceutical herbs
Kumar, A., Konar, A., Garg, S., Kaul, S. C., & Wadhwa, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105124 · Cited by 24
Withanolides, the hidden gem in Physalis minima: A mini review on their anti-inflammatory, anti-neuroinflammatory and anti-cancer effects
Lem, F. F., Yong, Y. S., Goh, S., Chin, S. N., & Chee, F. T. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2021.132002 · Cited by 24
Learning Deficits and Agenesis of Synapses and Myelinated Axons in Phosphoinositide-3 Kinase-Deficient Mice
Tohda, C., Nakanishi, R., & Kadowaki, M. (2006) · Neurosignals · doi:10.1159/000108936 · Cited by 24
4β-Hydroxywithanolide E isolated from Physalis pruinosa calyx decreases inflammatory responses by inhibiting the NF-κB signaling in diabetic mouse adipose tissue
Takimoto, T., Kanbayashi, Y., Toyoda, T., Adachi, Y., Furuta, C. S. H., Suzuki, K., Miwa, T., & Bannai, M. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.33 · Cited by 24
Dosha phenotype specific Ayurveda intervention ameliorates asthma symptoms through cytokine modulations: Results of whole system clinical trial
Joshi, K., Nesari, T. M., Dedge, A. P., Dhumal, V. R., Shengule, S. A., Gadgil, M. S., Salvi, S. S., & Valiathan, M. V. S. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.07.071 · Cited by 26
Withanolide a penetrates brain via intra-nasal administration and exerts neuroprotection in cerebral ischemia reperfusion injury in mice
Mukherjee, S., Kumar, G., & Patnaik, R. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1709228 · Cited by 24
Ashwagandha (Withania somnifera (L.) dunal) root extract containing withanolide a alleviates depression-like behavior in mice by enhancing the brain-derived neurotrophic factor pathway under unexpected chronic mild stress
Kim, H., Choi, H., Han, K., Sim, W., Suh, H. J., & Ahn, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119224 · Cited by 31
Ashwagandha (Withania somnifera) and Its Effects on Well-Being—A Review
Wiciński, M., Fajkiel-Madajczyk, A., Sławatycki, J., Szambelan, M., Szyperski, P., Wojciechowski, P., Wòjcicki, J., & Gawryjołek, M. (2025) · Nutrients · doi:10.3390/nu17132143 · Cited by 30
Epimedium koreanumExtract and Its Constituent Icariin Improve Motor Dysfunction in Spinal Cord Injury
Tohda, C., & Nagata, A. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/731208 · Cited by 23
An Insight in Pathophysiological Mechanism of Alzheimer's Disease and its Management Using Plant Natural Products
Firdaus, Z., & Singh, T. D. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200730155928 · Cited by 23
Rapid Micropropagation ofWithania somniferaL. Accessions from Axillary Meristems
Sabir, F., Sangwan, N. S., Chaurasiya, N. D., Misra, L. N., Tuli, R., & Sangwan, R. S. (2008) · Journal of Herbs Spices & Medicinal Plants · doi:10.1080/10496470801946166 · Cited by 22
Determination of permeability, plasma protein binding, blood partitioning, pharmacokinetics and tissue distribution of Withanolide A in rats: A neuroprotective steroidal lactone
Singh, S. K., Valicherla, G. R., Joshi, P., Shahi, S., Syed, A. A., Gupta, A. P., Hossain, Z., Italiya, K. S., Makadia, V., Singh, S. K., et al. (2018) · Drug Development Research · doi:10.1002/ddr.21463 · Cited by 21
Red laser-mediated alterations in seed germination, growth, pigments and withanolide content of Ashwagandha [Withania somnifera (L.) Dunal]
Thorat, S. A., Poojari, P., Kaniyassery, A., Kiran, K. R., Satyamoorthy, K., Mahato, K. K., & Muthusamy, A. (2021) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2021.112144 · Cited by 21
Induction of stress resistance and extension of lifespan in Chaenorhabditis elegans serotonin-receptor knockout strains by withanolide A
Naß, J., Abdelfatah, S., & Efferth, T. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153482 · Cited by 22
Chinese nutraceuticals and physical activity; their role in neurodegenerative tauopathies
Alausa, A. O., Ogundepo, S., Olaleke, B., Adeyemi, R. O., Olatinwo, M., & Ismail, A. (2021) · Chinese Medicine · doi:10.1186/s13020-020-00418-7 · Cited by 21
Systematic Review of the Therapeutic Role of Apoptotic Inhibitors in Neurodegeneration and Their Potential Use in Schizophrenia
Morén, C., Treder, N., Martínez-Pinteño, A., Rodríguez, N., Arbelo, N., Madero, S., Gómez, M., Mas, S., Gassó, P., & Parellada, E. (2022) · Antioxidants · doi:10.3390/antiox11112275 · Cited by 22
Withania somnifera: From Traditional Use to Evidence Based Medicinal Prominence
Rayees, S., & Malik, F. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-59192-6_4 · Cited by 20
Profiling withanolide A for therapeutic targets in neurodegenerative diseases
Crane, E. A., Heydenreuter, W., Beck, K. R., Strajhar, P., Vomacka, J., Smieško, M., Mons, E., Barth, L., Neuburger, M. A., Vedani, A., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.03.022 · Cited by 20
Traditional Medicine for Memory Enhancement
Howes, M. R., & Houghton, P. J. (2008) · Springer eBooks · doi:10.1007/978-3-540-79116-4_15 · Cited by 22
Withania somnifera Extract Protects Model Neurons from In Vitro Traumatic Injury
Saykally, J. N., Hatic, H., Keeley, K. L., Jain, S. C., Ravindranath, V., & Citron, B. A. (2017) · Cell Transplantation · doi:10.1177/0963689717714320 · Cited by 24
RP-HPLC Separation of Isomeric Withanolides: Method Development, Validation and Application to In situ Rat Permeability Determination
Malik, M. Y., Taneja, I., Kanumuri, R. S., Gayen, J. R., Singh, S. P., Sangwand, N. S., & Wahajuddin, M. (2017) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmx027 · Cited by 20
Biosynthesis of the triterpenoid withanolides in Withania somnifera
Narayanan, A. K., & Nagegowda, D. A. (2024) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2024.102576 · Cited by 19
Copy, Edit, and Paste: Natural Product Approaches to Biomaterials and Neuroengineering
Gademann, K. (2015) · Accounts of Chemical Research · doi:10.1021/ar500435b · Cited by 19
An in silico guided identification of nAChR agonists from Withania somnifera
Remya, C., Dileep, K., Variayr, E. J., & Sadasivan, C. (2016) · Frontiers in Life Science · doi:10.1080/21553769.2016.1207569 · Cited by 20
Correction: Water Extract of Ashwagandha Leaves Has Anticancer Activity: Identification of an Active Component and Its Mechanism of Action
Wadhwa, R., Singh, R., Gao, R., Shah, N., Widodo, N., Nakamoto, T., Ishida, Y., Terao, K., & Kaul, S. C. (2013) · PLoS ONE · doi:10.1371/annotation/b7059f27-5970-4734-8601-9913adcce984 · Cited by 19
Neurotrophe Naturstoffe – ihre Chemie und Biologie
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie · doi:10.1002/ange.201302268 · Cited by 18
A 12-deoxywithastramonolide-rich somaclonal variant in Withania somnifera (L.) Dunal—molecular cytogenetic analysis and significance as a chemotypic resource
Rana, S., Dhar, N., Bhat, W. W., Razdan, S., Khan, S., Dhar, R. S., Dutt, P., & Lattoo, S. K. (2012) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/s11627-012-9458-8 · Cited by 18
Ashwagandha: multiple health benefits
Bharti, V. K., Malik, J. K., & Gupta, R. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00050-1 · Cited by 20
Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer’s Disease
Liu, H., Jiang, Y., Liu, K., Gómez‐Murcia, V., Ma, X., Torrecillas, A., Chen, Q., Zhu, X., Lesnefsky, E. J., Gómez-Fernández, J. C., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01284 · Cited by 18
Overcoming Several Neurodegenerative Diseases by Traditional Medicines
Tohda, C. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.1159 · Cited by 18
A Systematic and Comprehensive Review on Withania somnifera (L.) Dunal- An Indian Ginseng
Bano, A., Sharma, N., Dhaliwal, H. S., & Sharma, V. (2015) · Journal of Pharmaceutical Research International · doi:10.9734/bjpr/2015/17102 · Cited by 19
Stem cells in the treatment of Alzheimer's disease – Promises and pitfalls
Bhatti, J. S., Khullar, N., Mishra, J., Kaur, S., Sehrawat, A., Sharma, E., Bhatti, G. K., Selman, A., & Reddy, P. H. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166712 · Cited by 19
Extracting β-amyloid from Alzheimer's disease
Dries, D. R., Yu, G., & Herz, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121560109 · Cited by 17
Estimation of antioxidant potential of individual components present in complex mixture ofWithania somnifera(Ashwagandha) root fraction by thin-layer chromatography-2,2-diphenyl-1-picrylhdrazyl method
Devkar, S. T., Jagtap, S., Katyare, S. S., & Hegde, M. V. (2014) · Journal of Planar Chromatography – Modern TLC · doi:10.1556/jpc.27.2014.3.2 · Cited by 17
Overview and Current Status of Alzheimer’s Disease in Bangladesh
Rahman, M. R., Tajmim, A., Ali, M., & Sharif, M. (2017) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170012 · Cited by 21
Biology‐Oriented Synthesis of a Withanolide‐Inspired Compound Collection Reveals Novel Modulators of Hedgehog Signaling
Švenda, J., Sheremet, M., Kremer, L., Maier, L., Bauer, J. O., Carsten Strohmann, B., Ziegler, S., Kumar, K., & Waldmann, H. (2015) · Angewandte Chemie · doi:10.1002/ange.201500112 · Cited by 16
Elucidation of gene clusters underlying withanolide biosynthesis in ashwagandha through yeast metabolic engineering
Reynolds, E. E., Trauger, M. A., Li, F., Huang, J., Moss, T., Christ, B., Xu, M., Knoch, E., & Weng, J. (2026) · Nature Plants · doi:10.1038/s41477-026-02220-z · Cited by 16
Neuroprotective Effect of Ashwagandha Extract against the Neurochemical Changes Induced in Rat Model of Hypothyroidism
Hosny, E. N., El-Gizawy, M. M., Sawie, H. G., Abdel-Wahhab, K. G., & Khadrawy, Y. A. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1713959 · Cited by 15
Viwithan, a Standardized Withania somnifera Root Extract Induces Apoptosis in Murine Melanoma Cells.
Sudeep, H. V., Gouthamchandra, K., Venkatesh, B., & Prasad, K. S. (2018) · PubMed Central · doi:10.4103/pm.pm_121_17 · Cited by 15
Synthese von Withanolid A, Untersuchung der neuritogenen Eigenschaften und Studien zur Sekretase‐Inhibierung
Jana, C. K., Hoecker, J., Woods, T. M., Jessen, H. J., Neuburger, M. A., & Gademann, K. (2011) · Angewandte Chemie · doi:10.1002/ange.201101869 · Cited by 14
Unveiling the effect of Withania somnifera on neuronal cytoarchitecture and synaptogenesis: A combined in vitro and network pharmacology approach
Mitra, S., Munni, Y. A., Dash, R., Sultana, A., & Moon, I. S. (2022) · Phytotherapy Research · doi:10.1002/ptr.7466 · Cited by 15
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship
Nishal, S., Phaugat, P., Bazaad, J., Dhaka, R., Khatkar, S., Khatkar, A., Khayatkashani, M., Alizadeh, P., Haghighi, S. M., Mehri, M., et al. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220614110616 · Cited by 16
Withanolides: Chemistry and Antitumor Activity
Choudhary, M. I., Sammer Yousuf, B., & Atta-ur-Rahman (2013) · Springer eBooks · doi:10.1007/978-3-642-22144-6_150 · Cited by 14
New Age Therapy for Alzheimer’s Disease by Neuronal Network Reconstruction
Tohda, C. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00438 · Cited by 14
Withanoside IV improves hindlimb function by facilitating axonal growth and increase in peripheral nervous system myelin level after spinal cord injury
Nakayama, N., & Tohda, C. (2007) · Neuroscience Research · doi:10.1016/j.neures.2007.02.014 · Cited by 14
Preclinical Evidence of Withania somnifera and Cordyceps spp.: Neuroprotective Properties for the Management of Alzheimer’s Disease
Tancreda, G., Ravera, S., & Panfoli, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115403 · Cited by 13
Effect of Pharmacological and Neurostimulation Interventions for Cognitive Domains in Patients with Bipolar Disorder: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Chen, W., Liu, H., Cheng, Y., Li, H., Huang, C., Ding, Y., Huang, M., Chiu, C., Tu, Y., & Kuo, P. (2021) · Clinical Epidemiology · doi:10.2147/clep.s335584 · Cited by 14
RETRACTED CHAPTER: Withanolide D, Carrying the Baton of Indian Rasayana Herb as a Lead Candidate of Antileukemic Agent in Modern Medicine
Mondal, S., Roy, S., Maity, R., Mallick, A., Sangwan, R. S., Misra‐Bhattacharya, S., & Mandal, C. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3381-1_20 · Cited by 13
Plant Adaptogens: Natural Medicaments for 21 st Century?
Özdemir, Z., Bildziukevich, U., Wimmerová, M., Macůrková, A., Lovecká, P., & Wimmer, Z. (2018) · ChemistrySelect · doi:10.1002/slct.201702682 · Cited by 17
Integrated System Pharmacology and In Silico Analysis Elucidating Neuropharmacological Actions of Withania somnifera in the Treatment of Alzheimer’s Disease
Hannan, M. A., Dash, R., Haque, M. N., Choi, S. M., & Moon, I. S. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319999200730214807 · Cited by 12
Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits
Vittal, M., & Vinciguerra, M. (2025) · Biogerontology · doi:10.1007/s10522-025-10320-0 · Cited by 11
Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer’s Disease
Pavlov, S. A., Prajapati, S. K., Yadav, D., Marcano-Rodriguez, A., Yadav, H., & Jain, S. (2025) · Biomolecules · doi:10.3390/biom16010007 · Cited by 13

Authors: Kuboyama, T., Tohda, C., & Komatsu, K.
Affiliations: University of Toyama (JP)
Institute of Natural Medicine, University of Toyama (JP)
Corresponding author: Komatsu, Katsuko
ORCID: Kuboyama, Tomoharu
Tohda, Chihiro
Komatsu, Katsuko
Venue: British Journal of Pharmacology
Publisher: Wiley
Published: 2005-04
Volume: 144
Issue: 7
Pages: 961-971
ISSN: 0007-1188 (ISSN-L)
1476-5381
DOI: 10.1038/sj.bjp.0706122
PMC: PMC1576076
OpenAlex: W2062620653
Cited by: 339
References: 45
Citations by year: 2026: 17 · 2025: 12 · 2024: 21 · 2023: 25 · 2022: 20 · 2021: 21 · 2020: 21 · 2019: 11 · 2018: 19 · 2017: 22 · 2016: 20 · 2015: 23 · 2014: 16 · 2013: 21 · 2012: 15
FWCI: 17.90
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1399 d)
Locations: British Journal of Pharmacology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords: withanolide A, Withania somnifera, neurite regeneration, axonal atrophy, dendritic atrophy, synaptic loss, amyloid beta 25-35, memory impairment, neurodegenerative diseases, neurofilament H, synaptophysin, PSD-95, cortical neurons, hippocampus, neuroprotection
MeSH terms: Animals, Cells, Cultured, Female, Nerve Regeneration, Plant Extracts, Pregnancy, Synapses, Neurites, Rats, Sprague-Dawley, Plant Roots, Withania, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuritic regeneration and synaptic reconstruction induced by withanolide A

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks